IL155997A0 - Protease inhibitors - Google Patents
Protease inhibitorsInfo
- Publication number
- IL155997A0 IL155997A0 IL15599701A IL15599701A IL155997A0 IL 155997 A0 IL155997 A0 IL 155997A0 IL 15599701 A IL15599701 A IL 15599701A IL 15599701 A IL15599701 A IL 15599701A IL 155997 A0 IL155997 A0 IL 155997A0
- Authority
- IL
- Israel
- Prior art keywords
- protease inhibitors
- protease
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25250800P | 2000-11-22 | 2000-11-22 | |
PCT/US2001/051647 WO2003053331A2 (en) | 2000-11-22 | 2001-11-19 | Protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
IL155997A0 true IL155997A0 (en) | 2003-12-23 |
Family
ID=22956303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15599701A IL155997A0 (en) | 2000-11-22 | 2001-11-19 | Protease inhibitors |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1392657A4 (es) |
JP (1) | JP2005513083A (es) |
KR (1) | KR20040004445A (es) |
CN (1) | CN1635903A (es) |
AR (1) | AR034278A1 (es) |
AU (1) | AU2001298052A1 (es) |
BR (1) | BR0115473A (es) |
CA (1) | CA2436850A1 (es) |
CZ (1) | CZ20031403A3 (es) |
HU (1) | HUP0301964A3 (es) |
IL (1) | IL155997A0 (es) |
MX (1) | MXPA03004542A (es) |
NO (1) | NO20032328L (es) |
PL (1) | PL366232A1 (es) |
UY (1) | UY27032A1 (es) |
WO (1) | WO2003053331A2 (es) |
ZA (1) | ZA200303848B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
US7071184B2 (en) | 2000-03-21 | 2006-07-04 | Smithkline Beecham Corporation | Protease inhibitors |
PL360508A1 (en) * | 2000-06-14 | 2004-09-06 | Smithkline Beecham Corporation | Protease inhibitors |
WO2008149971A1 (ja) | 2007-06-08 | 2008-12-11 | Kyoto University | 脳動脈瘤の治療または予防薬 |
JPWO2009054454A1 (ja) | 2007-10-24 | 2011-03-03 | 国立大学法人 東京医科歯科大学 | カテプシン阻害剤を有効成分として含有するToll様受容体のシグナル伝達の調整剤 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9916488A (pt) * | 1998-12-23 | 2001-10-09 | Smithkline Beecham Corp | Inibidores de protease |
US7071184B2 (en) * | 2000-03-21 | 2006-07-04 | Smithkline Beecham Corporation | Protease inhibitors |
PL360508A1 (en) * | 2000-06-14 | 2004-09-06 | Smithkline Beecham Corporation | Protease inhibitors |
-
2001
- 2001-11-19 CN CNA018220533A patent/CN1635903A/zh active Pending
- 2001-11-19 JP JP2003554091A patent/JP2005513083A/ja not_active Withdrawn
- 2001-11-19 WO PCT/US2001/051647 patent/WO2003053331A2/en not_active Application Discontinuation
- 2001-11-19 PL PL01366232A patent/PL366232A1/xx not_active Application Discontinuation
- 2001-11-19 KR KR10-2003-7006807A patent/KR20040004445A/ko not_active Application Discontinuation
- 2001-11-19 CZ CZ20031403A patent/CZ20031403A3/cs unknown
- 2001-11-19 CA CA002436850A patent/CA2436850A1/en not_active Abandoned
- 2001-11-19 IL IL15599701A patent/IL155997A0/xx unknown
- 2001-11-19 HU HU0301964A patent/HUP0301964A3/hu unknown
- 2001-11-19 EP EP01275089A patent/EP1392657A4/en not_active Withdrawn
- 2001-11-19 AU AU2001298052A patent/AU2001298052A1/en not_active Abandoned
- 2001-11-19 MX MXPA03004542A patent/MXPA03004542A/es unknown
- 2001-11-19 BR BR0115473-7A patent/BR0115473A/pt not_active Application Discontinuation
- 2001-11-20 AR ARP010105409A patent/AR034278A1/es unknown
- 2001-11-21 UY UY27032A patent/UY27032A1/es not_active Application Discontinuation
-
2003
- 2003-05-16 ZA ZA200303848A patent/ZA200303848B/en unknown
- 2003-05-22 NO NO20032328A patent/NO20032328L/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO20032328D0 (no) | 2003-05-22 |
CZ20031403A3 (cs) | 2003-10-15 |
AU2001298052A1 (en) | 2003-07-09 |
KR20040004445A (ko) | 2004-01-13 |
CN1635903A (zh) | 2005-07-06 |
ZA200303848B (en) | 2004-06-28 |
PL366232A1 (en) | 2005-01-24 |
EP1392657A4 (en) | 2004-03-10 |
WO2003053331A3 (en) | 2003-11-13 |
JP2005513083A (ja) | 2005-05-12 |
EP1392657A2 (en) | 2004-03-03 |
HUP0301964A2 (en) | 2007-02-28 |
MXPA03004542A (es) | 2003-09-10 |
AR034278A1 (es) | 2004-02-18 |
HUP0301964A3 (en) | 2007-09-28 |
NO20032328L (no) | 2003-07-02 |
WO2003053331A2 (en) | 2003-07-03 |
BR0115473A (pt) | 2004-09-28 |
CA2436850A1 (en) | 2003-07-03 |
UY27032A1 (es) | 2002-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2002002593A0 (en) | Protease inhibitors | |
GB0125445D0 (en) | Protease Inhibitors | |
IL215890A0 (en) | Peptidomimetic protease inhibitors | |
IL153421A0 (en) | Protease inhibitors | |
EP1235577A4 (en) | PROTEASE INHIBITORS | |
EP1232155A4 (en) | PROTEASE INHIBITORS | |
IL151087A0 (en) | Protease inhibitors | |
EP1229915A4 (en) | PROTEASE INHIBITORS | |
EP1231921A4 (en) | PROTEASE INHIBITORS | |
EP1229912A4 (en) | PROTEASE INHIBITORS | |
EP1229914A4 (en) | PROTEASE INHIBITORS | |
EP1229911A4 (en) | PROTEASE INHIBITORS | |
HK1044758A1 (zh) | 蛋白酶抑制劑 | |
EP1161237A4 (en) | PROTEASE INHIBITORS | |
EP1233771A4 (en) | PROTEASE INHIBITORS | |
EP1351930A4 (en) | PROTEASE INHIBITORS | |
EP1401453A4 (en) | PROTEASE INHIBITORS | |
EP1231923A4 (en) | PROTEASE INHIBITORS | |
HUP0301964A3 (en) | Protease inhibitors | |
IL155961A0 (en) | Cysteine protease inhibitors | |
EP1231922A4 (en) | PROTEASE INHIBITORS | |
EP1232154A4 (en) | PROTEASE INHIBITORS | |
AU6407701A (en) | Serine protease inhibitors | |
GB0009123D0 (en) | Protease inhibitor | |
ZA200207478B (en) | Protease inhibitors. |